U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C15H14O4
Molecular Weight 258.2693
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of XANTHOXYLETIN

SMILES

COC1=C2C=CC(C)(C)OC2=CC3=C1C=CC(=O)O3

InChI

InChIKey=JSJIIHRNDMLJGK-UHFFFAOYSA-N
InChI=1S/C15H14O4/c1-15(2)7-6-10-12(19-15)8-11-9(14(10)17-3)4-5-13(16)18-11/h4-8H,1-3H3

HIDE SMILES / InChI

Description

Xanthoxyletin is a coumarin isolated from Erythrina variegata. It has been reported that Xanthoxyletin possesses antibacterial, fungicidal, and algicidal properties. Xanthoxyletin induces S phase arrest and apoptosis in human gastric adenocarcinoma SGC-7901 cells. Xanthoxyletin may be promising anticancer agent and has worth for further mechanistic and therapeutic studies against gastric cancer.

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
0.74 µM [Ki]
0.96 µM [Ki]
3.15 µM [Ki]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
After treating the SGC-7901 cells with 200 and 400 uM of Xanthoxyletin for 48 h, ROS production was detected and the ratios of DCF-positive cells were 18.66% and 32.86% respectively as compared to 8.27% in the control group. Xanthoxyletin induced apoptosis in SGC-7901 cells and percentage of apoptotic cells was 41.47% after the exposure of 400 uM of Xanthoxyletin for 48 h as compared to 2.6% in the control group.